Crossmark

How do patients with head and neck cancer and low skeletal muscle mass experience cisplatin-based chemoradiotherapy? A qualitative study

Published Online: 2024-10-28

Published Print: 2024-11

Authors

Schaeffers, Anouk W. M. A.

van Beers, Maartje A.

Devriese, Lot A.

Klomp, F. W. José

Westerink - van den Brink, Chantal F. M.

Smid, Ernst J.

de Bree, Remco

Speksnijder, Caroline M.
Funding

Funding for this research was provided by:

ZonMw (10140021910002)
License Information

Text and Data Mining valid from 2024-10-28

Version of Record valid from 2024-10-28
More Information

Article History

Received: 22 February 2024

Accepted: 18 October 2024

First Online: 28 October 2024

Declarations

:

: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the University Medical Center Utrecht (29–07-2021/No 21–329/GD).

: Written informed consent was obtained from all individual participants included in the study.

: The authors declare no competing interests.

Document is current